{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:04:15Z","timestamp":1780380255090,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["309608"],"award-info":[{"award-number":["309608"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009047","name":"Strategic Research Council","doi-asserted-by":"publisher","award":["320210"],"award-info":[{"award-number":["320210"]}],"id":[{"id":"10.13039\/501100009047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009047","name":"Strategic Research Council","doi-asserted-by":"publisher","award":["346568"],"award-info":[{"award-number":["346568"]}],"id":[{"id":"10.13039\/501100009047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aquatic Toxicology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.aquatox.2024.107048","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T13:59:36Z","timestamp":1723384776000},"page":"107048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative in vitro hepatic clearances of commonly used antidepressants, antipsychotics, and anti-inflammatory agents in rainbow trout liver S9 fractions"],"prefix":"10.1016","volume":"274","author":[{"given":"Tea L.M.","family":"Pihlaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"P\u00e4tsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ollikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-1301","authenticated-orcid":false,"given":"Tiina M.","family":"Sikanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.aquatox.2024.107048_bib0001","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/etc.3680","article-title":"Assessing the bioaccumulation potential of ionizable organic compounds: current knowledge and research priorities","volume":"36","author":"Armitage","year":"2017","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.aquatox.2024.107048_bib0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/qsar.200390023","article-title":"A generic QSAR for assessing the bioaccumulation potential of organic chemicals in aquatic food webs","volume":"22","author":"Arnot","year":"2003","journal-title":"QSAR Comb. Sci."},{"issue":"4","key":"10.1016\/j.aquatox.2024.107048_bib0003","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/etc.3339","article-title":"Pharmaceuticals in the environment\u2014Global occurrences and perspectives","volume":"35","author":"Aus der Beek","year":"2016","journal-title":"Environ. Toxicol. Chem."},{"issue":"6","key":"10.1016\/j.aquatox.2024.107048_bib0004","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pharep.2015.04.005","article-title":"Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: an in vitro study","volume":"67","author":"Basi\u0144ska-Ziobro\u0144","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.aquatox.2024.107048_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/187231208783478407","article-title":"An examination of IC50 and IC50-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6 and CYP2C9 in human liver microsomes","volume":"2","author":"Berry","year":"2008","journal-title":"Drug Metab. Lett."},{"issue":"3","key":"10.1016\/j.aquatox.2024.107048_bib0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.etap.2007.06.005","article-title":"Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma","volume":"24","author":"Brown","year":"2007","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0007","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.chemosphere.2013.01.050","article-title":"Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout","volume":"92","author":"Burkina","year":"2013","journal-title":"Chemosphere"},{"issue":"11","key":"10.1016\/j.aquatox.2024.107048_bib0008","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/molecules25112690","article-title":"In vitro metabolic transformation of pharmaceuticals by hepatic S9 fractions from common carp (Cyprinus carpio)","volume":"25","author":"Burkina","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.aquatox.2024.107048_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2021.01.011","article-title":"Tissue-specific expression and activity of cytochrome P450 1A and 3A in rainbow trout (Oncorhynchus mykiss)","volume":"341","author":"Burkina","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.aquatox.2024.107048_bib0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.aquatox.2011.06.002","article-title":"Cocktail effects on biomarker responses in fish","volume":"105S","author":"Celander","year":"2011","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106188","article-title":"Neuroactive drugs and other pharmaceuticals found in blood plasma of wild European fish","volume":"146","author":"Cerveny","year":"2021","journal-title":"Environ. Int."},{"issue":"23","key":"10.1016\/j.aquatox.2024.107048_bib0012","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1021\/acs.est.6b03504","article-title":"Which molecular features affect the intrinsic hepatic clearance rate of ionizable organic chemicals in fish?","volume":"50","author":"Chen","year":"2016","journal-title":"Environ. Sci. Technol."},{"issue":"12","key":"10.1016\/j.aquatox.2024.107048_bib0013","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1897\/08-483.1","article-title":"A microtiter-plate-based cytochrome P450 3A activity assay in fish cell lines","volume":"28","author":"Christen","year":"2009","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.aquatox.2024.107048_bib0015","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/etc.2240","article-title":"Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions","volume":"32","author":"Connors","year":"2013","journal-title":"Environ. Toxicol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.aquatox.2024.107048_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/1062936X.2011.623321","article-title":"Simulation of chemical metabolism for fate and hazard assessment. III. New developments of the bioconcentration factor base-line model","volume":"23","author":"Dimitrov","year":"2012","journal-title":"SAR QSAR Environ. Res."},{"issue":"7","key":"10.1016\/j.aquatox.2024.107048_bib0017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hup.328","article-title":"In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes","volume":"16","author":"Dodd","year":"2001","journal-title":"Hum. Psychopharmacol."},{"issue":"21","key":"10.1016\/j.aquatox.2024.107048_bib0018","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1021\/acs.est.0c04839","article-title":"New conceptual toxicokinetic model to assess synergistic mixture effects between the aromatic hydrocarbon \u03b2-naphthoflavone and the azole nocodazole on the CYP1A biomarker in a fish cell line","volume":"54","author":"Fallahi","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0019","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1021\/es500952a","article-title":"Intra- and interlaboratory reliability of a cryopreserved trout hepatocyte assay for the prediction of chemical bioaccumulation potential","volume":"48","author":"Fay","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0020","unstructured":"FDA, U.S. Department of Health and Human Services, Food and Drug Administration. 2018. Bioanalytical Method Validation Guidance for Industry. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"key":"10.1016\/j.aquatox.2024.107048_bib0021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.fct.2014.03.035","article-title":"Predicting the bioconcentration factor of highly hydrophobic organic chemicals","volume":"69","author":"Garg","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.aquatox.2024.107048_bib0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00128-011-0200-8","article-title":"Ibuprofen metabolism in the liver and gill of rainbow trout, Oncorhynchus mykiss","volume":"86","author":"Gomez","year":"2011","journal-title":"Bull. Environ. Contam. Toxicol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.160638","article-title":"Bioaccumulation\/bioconcentration of pharmaceutical active compounds in aquatic organisms: assessment and factors database","volume":"861","author":"G\u00f3mez-Regalado","year":"2023","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.aquatox.2024.107048_bib0024","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.watres.2017.08.018","article-title":"Bioaccumulation of psychoactive pharmaceuticals in fish in an effluent dominated stream","volume":"124","author":"Grabicova","year":"2017","journal-title":"Water Res."},{"issue":"7","key":"10.1016\/j.aquatox.2024.107048_bib0025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1124\/dmd.109.026716","article-title":"The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America","volume":"37","author":"Grimm","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.aquatox.2024.107048_bib0026","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.envint.2019.04.075","article-title":"Pharmacology beyond the patient\u2014The environmental risks of human drugs","volume":"129","author":"Gunnarsson","year":"2019","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.aquatox.2024.107048_bib0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-2952(97)00143-3","article-title":"Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C","volume":"54","author":"Hamman","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.aquatox.2024.107048_bib0028","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-5926-4-2","article-title":"Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua)","volume":"4","author":"Hasselberg","year":"2005","journal-title":"Comp. Hepatol."},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0029","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.aquatox.2007.11.006","article-title":"Ketoconazole, an antifungal imidazole, increases the sensitivity of rainbow trout to 17alpha-ethynylestradiol exposure","volume":"86","author":"Hasselberg","year":"2008","journal-title":"Aquat. Toxicol."},{"issue":"5","key":"10.1016\/j.aquatox.2024.107048_bib0030","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1897\/03-155","article-title":"Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish","volume":"23","author":"Hegelund","year":"2004","journal-title":"Environ. Toxicol. Chem."},{"issue":"3","key":"10.1016\/j.aquatox.2024.107048_bib0031","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.aquatox.2006.06.006","article-title":"Cytochrome P4501A induction in rainbow trout gills and liver following exposure to waterborne indigo, benzo[a]pyrene and 3,3\u2032,4,4\u2032,5-pentachlorobiphenyl","volume":"79","author":"J\u00f6nsson","year":"2006","journal-title":"Aquat. Toxicol."},{"issue":"1","key":"10.1016\/j.aquatox.2024.107048_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/61.1.49","article-title":"Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac","volume":"61","author":"King","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.aquatox.2024.107048_bib0033","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/etc.4791","article-title":"Comparison of alternative methods for bioaccumulation assessment: scope and limitations of in vitro depletion assays with rainbow trout and bioconcentration tests in the freshwater amphipod Hyalella Azteca","volume":"39","author":"Kosfeld","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.aquatox.2024.107048_bib0034","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/etc.4872","article-title":"In vitro biotransformation assays using liver S9 fractions and hepatocytes from rainbow trout (Oncorhynchus mykiss): overcoming challenges with difficult to test fragrance chemicals","volume":"39","author":"Kropf","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"issue":"7","key":"10.1016\/j.aquatox.2024.107048_bib0035","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/dmd.104.002527","article-title":"Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes","volume":"33","author":"Kuehl","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.aquatox.2024.107048_bib0036","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.scitotenv.2019.03.372","article-title":"Comparison of regulatory frameworks of environmental risk assessments for human pharmaceuticals in EU, USA, and Canada","volume":"671","author":"Lee","year":"2019","journal-title":"Sci. Total Environ."},{"issue":"1","key":"10.1016\/j.aquatox.2024.107048_bib0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/abbi.1998.0943","article-title":"Cloning, sequencing, and tissue expression of CYP3A27, a new member of the CYP3A subfamily from embryonic and adult rainbow trout livers","volume":"360","author":"Lee","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0038","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/etc.5620160228","article-title":"Effect of the fungicide clotrimazole on the bioconcentration of benzo[a]pyrene in gizzard shad (Dorosoma cepedianum): in vivo and in vitro inhibition of cytochrome P4501A activity","volume":"16","author":"Levine","year":"1997","journal-title":"Environ. Toxicol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.aquatox.2024.107048_bib0039","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-2797(02)00051-0","article-title":"A review of the common properties of drugs with idiosyncratic hepatotoxicity and the ``multiple determinant hypothesis'' for the manifestation of idiosyncratic drug toxicity","volume":"142","author":"Li","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.aquatox.2024.107048_bib0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01952257","article-title":"Combinated effects I announcement\u2013implements to the problem","volume":"114","author":"Loewe","year":"1926","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"issue":"8","key":"10.1016\/j.aquatox.2024.107048_bib0041","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bdd.1857","article-title":"Time-dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor","volume":"34","author":"Masubuchi","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0042","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/taap.1997.8341","article-title":"Evaluation of chemicals as inhibitors of trout cytochrome P450s","volume":"148","author":"Miranda","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0043","doi-asserted-by":"crossref","first-page":"16999","DOI":"10.1038\/s41598-017-15462-x","article-title":"Bioaccumulation of pharmaceuticals and personal care product chemicals in fish exposed to wastewater effluent in an urban wetland","volume":"7","author":"Muir","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.aquatox.2024.107048_bib0044","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/toxsci\/kfy113","article-title":"Reliability of in vitro methods used to measure intrinsic clearance of hydrophobic organic chemicals by rainbow trout: results of an international ring trial","volume":"164","author":"Nichols","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"7","key":"10.1016\/j.aquatox.2024.107048_bib0045","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/etc.2219","article-title":"Toward improved models for predicting bioconcentration of well-metabolized compounds by rainbow trout using measured rates of in vitro intrinsic clearance","volume":"32","author":"Nichols","year":"2013","journal-title":"Environ. Toxicol. Chem."},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0046","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0047","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2125.1996.tb00173.x","article-title":"Venlafaxine oxidation in vitro is catalysed by CYP2D6","volume":"41","author":"Otton","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.aquatox.2024.107048_bib0048","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008571-199810000-00003","article-title":"In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol","volume":"8","author":"Pan","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.aquatox.2024.107048_bib65","unstructured":"PharmGKB. 2023. Available at: https:\/\/www.pharmgkb.org\/."},{"issue":"3","key":"10.1016\/j.aquatox.2024.107048_bib0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/etc.5160","article-title":"Cytochrome P450 inhibition by antimicrobials and their mixtures in rainbow trout liver microsomes in vitro","volume":"41","author":"Pihlaja","year":"2022","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.aquatox.2024.107048_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2024.1406942","article-title":"Many human pharmaceuticals are weak inhibitors of the cytochrome P450 system in rainbow trout (Oncorhynchus mykiss) liver S9 fraction","volume":"6","author":"Pihlaja","year":"2024","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0052","doi-asserted-by":"crossref","first-page":"D237","DOI":"10.1093\/nar\/gkp970","article-title":"SuperCYP: a comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions","volume":"38","author":"Preissner","year":"2010","journal-title":"Nucleic Acid Res."},{"key":"10.1016\/j.aquatox.2024.107048_bib0053","first-page":"579","article-title":"Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology","volume":"37","author":"Rovida","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.aquatox.2024.107048_bib0054","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.aquatox.2011.08.022","article-title":"In vitro inhibition of cytochrome P450\u2013mediated reactions by gemfibrozil, erythromycin, ciprofloxacin and fluoxetine in fish liver microsomes","volume":"109","author":"Smith","year":"2012","journal-title":"Aquat. Toxicol."},{"issue":"4","key":"10.1016\/j.aquatox.2024.107048_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s002280050293","article-title":"Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation","volume":"52","author":"Tracy","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.aquatox.2024.107048_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.etap.2012.02.004","article-title":"Cytochrome P450 (CYP) in fish","volume":"34","author":"Uno","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.aquatox.2024.107048_bib64","unstructured":"US EPA (United States Environmental Protection Agency). 2023. Comptox Chemicals Dashboard. Available at: https:\/\/comptox.epa.gov\/."},{"issue":"8","key":"10.1016\/j.aquatox.2024.107048_bib0057","first-page":"1102","article-title":"Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram","volume":"29","author":"von Moltke","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.aquatox.2024.107048_bib0058","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1021\/acs.est.1c08068","article-title":"A generalized physiologically based kinetic model for fish for environmental risk assessment of pharmaceuticals","volume":"56","author":"Wang","year":"2022","journal-title":"Environ. Sci. Technol."},{"issue":"8","key":"10.1016\/j.aquatox.2024.107048_bib0059","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113947119","article-title":"Pharmaceutical pollution of the world's rivers","volume":"119","author":"Wilkinson","year":"2022","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.aquatox.2024.107048_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2014.05.005","article-title":"The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application","volume":"90","author":"W\u00f3jcikowski","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.aquatox.2024.107048_bib0061","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-2125.1999.00023.x","article-title":"Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes","volume":"48","author":"Xu","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.aquatox.2024.107048_bib0062","first-page":"1263","article-title":"Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes","volume":"29","author":"Yasui-Furukori","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.aquatox.2024.107048_bib0063","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."}],"container-title":["Aquatic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166445X24002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166445X24002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:54:00Z","timestamp":1725483240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166445X24002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":63,"alternative-id":["S0166445X24002182"],"URL":"https:\/\/doi.org\/10.1016\/j.aquatox.2024.107048","relation":{},"ISSN":["0166-445X"],"issn-type":[{"value":"0166-445X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative in vitro hepatic clearances of commonly used antidepressants, antipsychotics, and anti-inflammatory agents in rainbow trout liver S9 fractions","name":"articletitle","label":"Article Title"},{"value":"Aquatic Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aquatox.2024.107048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107048"}}